4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-20-065501
Chief Executive Officer acquired 13,800 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kulkarni Samarth Chief Executive Officer | 2020-12-29 | Option exercise | +13,800 | $1.81 | $24,978 | 182,989 | D |
| Derivatives | |||||||
| Kulkarni Samarth Chief Executive Officer | 2020-12-29 | Option exercise · Stock Option (right to buy) | −13,800 | 128,983 | D | ||
Loading xslF345X03/doc4.xml…